ID
44723
Beschrijving
TACkLE Study - Tackling Adverse Chemotherapy-associated Late Effects; ODM derived from: https://clinicaltrials.gov/show/NCT02276430
Link
https://clinicaltrials.gov/show/NCT02276430
Trefwoorden
Versies (1)
- 28-09-21 28-09-21 -
Houder van rechten
University Medical Center Groningen The Netherlands Cancer Institute
Geüploaded op
28 september 2021
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Testicular Cancer NCT02276430
Eligibility Testicular Cancer NCT02276430
- StudyEvent: Eligibility
Beschrijving
in order to be eligible to participate in the cardiometabolic risk inventory study (and to be invited to a study assessment), a subject must meet, next to the criteria mentioned in "1)", the following inclusion criteria:
Alias
- UMLS CUI [1]
- C1512693
Beschrijving
Age at the tc diagnosis
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0153594
- UMLS CUI [1,2]
- C1828181
Beschrijving
Age at the moment of inclusion
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0001779
- UMLS CUI [1,2]
- C1512693
- UMLS CUI [1,3]
- C0681850
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Similar models
Eligibility Testicular Cancer NCT02276430
- StudyEvent: Eligibility
C2316983 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,2])
C1301943 (UMLS CUI [1,3])
C1828181 (UMLS CUI [1,2])
C1956346 (UMLS CUI [2,1])
C2985911 (UMLS CUI [2,2])
C0018802 (UMLS CUI [3,1])
C2985911 (UMLS CUI [3,2])
C0262926 (UMLS CUI [1,2])
C0153594 (UMLS CUI [1,3])
C0332152 (UMLS CUI [1,4])
C0332197 (UMLS CUI [1,5])
C1828181 (UMLS CUI [1,2])
C1512693 (UMLS CUI [1,2])
C0681850 (UMLS CUI [1,3])
C0205177 (UMLS CUI [1,2])